The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Acute promyelocytic leukemia: evolving therapeutic strategies
Abstract
Acute promyelocytic leukemia (APL) is now the most curable subtype of acute myeloid leukemia in adults. All-trans retinoic acid (ATRA), which induces differentiation of the leukemic cells into mature granulocytes, represents the important advance. The incorporation of ATRA in induction results in a high complete remission rate, leads to rapid resolution of the characteristic life-threatening coagulopathy, and, most importantly, decreases the relapse rate compared with treatment with chemotherapy alone. However, ATRA is associated with unique toxicities not observed with conventional cytotoxic chemotherapy. A number of clinical trials have been performed to define the optimal role of ATRA in the treatment of patients. The therapeutic strategies have rapidly evolved as a result of both single institution and large cooperative group trials. Arsenic trioxide and stem cell transplantation are effective treatments for patients with APL who relapse after or are refractory to ATRA-based therapy. As experience with ATRA and arsenic trioxide in patients with APL accumulates, a number of important questions arise that need to be addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Huang, M., Ye, Y., Chen, Sr., Chai, Jr., Lu, J., Zhoa, L., Gu, L., & Wang, Z. (1988) · Blood · doi:10.1182/blood.v72.2.567.567 · Cited by 2,445
Shen, Z.-X., Chen, G.-Q., Ni, J.-H., Li, X.-S., Xiong, S.-M., Qiu, Q.-Y., Zhu, J., Tang, W., Sun, G.-L., Yang, K.-Q., et al. (1997) · Blood · doi:10.1182/blood.v89.9.3354 · Cited by 1,428
Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)
Warrell, R. P., Frankel, S. R., Miller, W. H., Scheinberg, D. A., Itri, L. M., Hittelman, W. N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105163242002 · Cited by 1,251
Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
Soignet, S. L., Maslak, P., Wang, Z.-G., Jhanwar, S., Calleja, E., Dardashti, L. J., Corso, D., DeBlasio, A., Gabrilove, J., Scheinberg, D. A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391901 · Cited by 1,213
Castaigne, S., Chomienne, C., Daniel, M., Ballerini, P., Berger, R., Fenaux, P., & Degos, L. (1990) · Blood · doi:10.1182/blood.v76.9.1704.1704 · Cited by 1,184
All-trans-Retinoic Acid in Acute Promyelocytic Leukemia
Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R., Feusner, J. H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C. D., Rowe, J. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371501 · Cited by 1,073
Self-citationChen, G., Zhu, J., Shi, X., Ni, J., Zhong, H., Si, G., Jin, X., Tang, W., Li, X., Xong, S., et al. (1996) · Blood · doi:10.1182/blood.v88.3.1052.1052 · Cited by 864
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
Soignet, S. L., Frankel, S. R., Douer, D., Tallman, M. S., Kantarjian, H., Calleja, E., Stone, R. M., Kalaycio, M., Scheinberg, D. A., Steinherz, P., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3852 · Cited by 826
Self-citationChen, G., Shi, X., Tang, W., Xiong, S. M., Zhu, J., Cai, X., Han, Z., Ni, J.-H., Shi, G., Jia, P.-M., et al. (1997) · PubMed · Cited by 781
Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion
LEGHA, S. S., BENJAMIN, R. S., MACKAY, B., EWER, M., WALLACE, S., VALDIVIESO, M., RASMUSSEN, S. L., BLUMENSCHEIN, G. R., & FREIREICH, E. J. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-2-133 · Cited by 763
Fenaux, P., Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., Fey, M., Rayon, C., Huguet, F., Sotto, J.-J., et al. (1999) · Blood · doi:10.1182/blood.v94.4.1192 · Cited by 754
Sanz, M. Á., Coco, F. L., Martín, G., Avvisati, G., Rayón, C., Barbui, T., Diaz‐Mediavilla, J., Fioritoni, G., González, J. D., Liso, V., et al. (2000) · PubMed · Cited by 632
Niu, C., Yan, H., Yu, T., Sun, H.-P., Liu, J.-X., Li, X.-S., Wu, W., Zhang, F.-Q., Chen, Y., Zhou, L., et al. (1999) · Blood · doi:10.1182/blood.v94.10.3315.422k16_3315_3324 · Cited by 625
Jing, Y., Dai, J., Chalmers-Redman, R. M. E., Tatton, W. G., & Waxman, S. (1999) · Blood · doi:10.1182/blood.v94.6.2102 · Cited by 543
Fenaux, P., Le Deley, M., Castaigne, S., Archimbaud, E., Chomienne, C., Link, H., Guerci, A., Duarte, M., Daniel, M., & Bowen, D. (1993) · Blood · doi:10.1182/blood.v82.11.3241.3241 · Cited by 516
Lazo, G., Kantarjian, H., Estey, E., Thomas, D., O'Brien, S., & Cortes, J. (2003) · Cancer · doi:10.1002/cncr.11314 · Cited by 494
Krischer, J. P., Epstein, S., Cuthbertson, D. D., Goorin, A. M., Epstein, M. L., & Lipshultz, S. E. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1544 · Cited by 476
Mandelli, F., Diverio, D., Avvisati, G., Luciano, A., Barbui, T., Bernasconi, C., Broccia, G., Cerri, R., Falda, M., Fioritoni, G., et al. (1997) · PubMed · doi:10.1182/blood.v90.3.1014 · Cited by 474
Sanz, M. Á., Martín, G., Rayón, C., Esteve, J., González, M., Diaz‐Mediavilla, J., Bolufer, P., Barragán, E., Terol, M. J., González, J. D., et al. (1999) · PubMed · Cited by 408
Chen, Z., Xue, Y., Zhang, R., Tao, R., Xia, X., Li, C., Wang, W., Zu, W., Yao, X., & Ling, B. (1991) · Blood · doi:10.1182/blood.v78.6.1413.1413 · Cited by 399
Shao, W., Fanelli, M., Ferrara, F. F., Riccioni, R., Rosenauer, A., Davison, K., Lamph, W. W., Waxman, S., Pelicci, P. G., Lo Coco, F., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.2.124 · Cited by 344
De Botton, S., Dombret, H., Sanz, M., Miguel, J. S., Caillot, D., Zittoun, R., Gardembas, M., Stamatoulas, A., Condé, E., Guerci, A., et al. (1998) · Blood · doi:10.1182/blood.v92.8.2712 · Cited by 339
Acute Promyelocytic Leukemia: Results of Treatment by Daunorubicin
Bernard, J., Weil, M., Boiron, M., Jacquillat, C., Flandrin, G., & Gemon, M.-F. (1973) · Blood · doi:10.1182/blood.v41.4.489.489 · Cited by 338
Diverio, D., Rossi, V., Avvisati, G., DeSantis, S., Pistilli, A., Pane, F., Saglio, G., Martinelli, G., Petti, M. C., Santoro, A., et al. (1998) · Blood · doi:10.1182/blood.v92.3.784 · Cited by 305
Vahdat, L., Maslak, P., Miller, W. J., Eardley, A., Heller, G., Scheinberg, D., & Warrell, R. J. (1994) · Blood · doi:10.1182/blood.v84.11.3843.bloodjournal84113843 · Cited by 296
Fang, G., Kim, C. N., Perkins, C. L., Ramadevi, N., Winton, E., Wittmann, S., & Bhalla, K. N. (2000) · Blood · doi:10.1182/blood.v96.6.2246 · Cited by 269
All-trans Retinoic Acid for Acute Promyelocytic Leukemia: Results of the New York Study
Frankel, S. R., Eardley, A., Heller, G., Berman, E., Miller, W. H., Dmitrovsky, E., & Warrell, R. P. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-4-199402150-00004 · Cited by 262
Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R., Feusner, J. H., Ogden, A., Shepherd, L. E., Rowe, J. M., François, C. J., Larson, R. A., et al. (2000) · PubMed · doi:10.1182/blood.v95.1.90 · Cited by 259
Self-citationMiller, W. H., Kakizuka, A., Frankel, S. R., Warrell, R. P., DeBlasio, A., Levine, K., Evans, R. M., & Dmitrovsky, E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2694 · Cited by 256
Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide
Westervelt, P., Brown, R. A., Adkins, D. R., Khoury, H., Curtin, P., Hurd, D., Luger, S. M., Ma, M. K., Ley, T. J., & DiPersio, J. F. (2001) · Blood · doi:10.1182/blood.v98.2.266 · Cited by 245
Avvisati, G., Lo Coco, F., Diverio, D., Falda, M., Ferrara, F., Lazzarino, M., Russo, D., Petti, M., & Mandelli, F. (1996) · Blood · doi:10.1182/blood.v88.4.1390.bloodjournal8841390 · Cited by 244
Fenaux, P., Castaigne, S., Dombret, H., Archimbaud, E., Duarte, M., Morel, P., Lamy, T., Tilly, H., Guerci, A., & Maloisel, F. (1992) · Blood · doi:10.1182/blood.v80.9.2176.2176 · Cited by 232
Therapy of Molecular Relapse in Acute Promyelocytic Leukemia
Coco, F. L., Diverio, D., Avvisati, G., Petti, M. C., Meloni, G., Pogliani, E. M., Biondi, A., Rossi, G., Carlo-Stella, C., Selleri, C., et al. (1999) · Blood · doi:10.1182/blood.v94.7.2225.419k03_2225_2229 · Cited by 229
Genetic Diagnosis and Molecular Monitoring in the Management of Acute Promyelocytic Leukemia
Coco, F. L., Diverio, D., Falini, B., Biondi, A., Nervi, C., & Pelicci, P. G. (1999) · Blood · doi:10.1182/blood.v94.1.12.413a44_12_22 · Cited by 216
Jing, Y., Wang, L., Xia, L., Chen, G.-Q., Chen, Z., Miller, W. H., & Waxman, S. (2001) · Blood · doi:10.1182/blood.v97.1.264 · Cited by 204
Guglielmi, C., Paola Martelli, M., Diverio, D., Fenu, S., Luce Vegna, M., CantÙ‐Rajnoldi, A., Biondi, A., Grazia Cocito, M., Del Vecchio, L., Tabilio, A., et al. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00871.x · Cited by 198
Douer, D., Preston-Martin, S., Chang, E., Nichols, P., Watkins, K., & Levine, A. (1996) · Blood · doi:10.1182/blood.v87.1.308.308 · Cited by 179
Camacho, L. H., Soignet, S. L., Chanel, S., Ho, R., Heller, G., Scheinberg, D. A., Ellison, R., & Warrell, R. P. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.13.2620 · Cited by 174
Ferrara, F., Morabito, F., Martino, B., Specchia, G., Liso, V., Nobile, F., Boccuni, P., Di Noto, R., Pane, F., Annunziata, M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.6.1295 · Cited by 171
Lengfelder, E., Reichert, A., Schoch, C., Haase, D., Haferlach, T., Löffler, H., Staib, P., Heyll, A., Seifarth, W., Saussele, S., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401843 · Cited by 162
Jurcic, J. G., DeBlasio, T., Dumont, L., Yao, T., & Scheinberg, D. A. (2000) · PubMed · Cited by 159
Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer.
Smith, M. A., Adamson, P. C., Balis, F. M., Feusner, J. H., Aronson, L., Murphy, R. F., Horowitz, M. E., Reaman, G. H., Hammond, G. D., & FENTON, R. M. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.11.1666 · Cited by 151
Self-citationIncreased risk of cardiac dysfunction after anthracyclines in girls
Silber, J. H., Jakacki, R. I., Larsen, R. L., Goldwein, J. W., & Barber, G. (1993) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950210704 · Cited by 151
Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia
Head, D., Kopecky, K., Weick, J. K., Files, J., Ryan, D., Foucar, K. K., Montiel, M., Bickers, J., Fishleder, A. J., & Miller, M. (1995) · Blood · doi:10.1182/blood.v86.5.1717.bloodjournal8651717 · Cited by 132
CD56 Expression in Acute Promyelocytic Leukemia: A Possible Indicator of Poor Treatment Outcome?
Murray, C. K., Estey, E. H., Paietta, E. M., Howard, R. S., Edenfield, W. J., Pierce, S., Mann, K. P., Bolan, C. D., & Byrd, J. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.293 · Cited by 132
Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine.
Estey, E., Thall, P. F., Pierce, S., Kantarjian, H., & Keating, M. J. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.483 · Cited by 125
Gallagher, R. E., Willman, C. L., Slack, J. L., Andersen, J. W., Li, Y., Viswanatha, D. S., Bloomfield, C. D., Appelbaum, F. R., Schiffer, C. A., Tallman, M. S., et al. (1997) · Blood · doi:10.1182/blood.v90.4.1656.1656_1656_1663 · Cited by 122
Self-citationSlack, J. L., Arthur, D., Lawrence, D. D., Mrózek, K., Mayer, R. J., Davey, F. R., Tantravahi, R. V., Pettenati, M. J., Bigner, S. H., Carroll, A. J., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.1786 · Cited by 114
Wiley, J. S., & Firkin, F. C. (1995) · PubMed · Cited by 111
Paietta, E. M., Andersen, J., Racevskis, J., Gallagher, R. J., Bennett, J. M., Yunis, J. J., Cassileth, P. A., & Wiernik, P. H. (1994) · PubMed · Cited by 107
Estey, E. H., Giles, F. J., Kantarjian, H., O’Brien, S., Cortes, J., Freireich, E. J., Lopez-Berestein, G., & Keating, M. (1999) · Blood · doi:10.1182/blood.v94.7.2230.419k05_2230_2235 · Cited by 105
Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia
Hiorns, L. R., Swansbury, G. J., Mehta, J., Min, T., Dainton, M., Treleaven, J. G., Powles, R., & Catovsky, D. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.d01-2037.x · Cited by 99
Mann, G., Reinhardt, D., Ritter, J., Hermann, J., Schmitt, K., Gadner, H., & Creutzig, U. (2001) · Annals of Hematology · doi:10.1007/s002770100304 · Cited by 98
Ko, B., Tang, J.-L., Chen, Y., Yao, M., Wang, C.-H., Shen, M.-C., & Tien, H.-F. (1999) · Leukemia · doi:10.1038/sj.leu.2401495 · Cited by 88
Douer, D., Estey, E. H., Santillana, S., Bennett, J. M., Lopez-Bernstein, G., Boehm, K. A., & Williams, T. (2001) · Blood · doi:10.1182/blood.v97.1.73 · Cited by 81
Avvisati, G., Mandelli, F., Petti, M. C., Vegna, M. L., Spadea, A., Liso, V., Specchia, G., Bernasconi, C., Alessandrino, E. P., Piatti, C., et al. (1990) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1990.tb00389.x · Cited by 76
Chiba, R., Nakagawa, N., Kurasawa, K., Tanaka, Y., Saito, Y., & Iwamoto, I. (1999) · Blood · doi:10.1182/blood.v94.4.1319 · Cited by 73
[Acute promyelocytic leukemia: retrospective study of 119 patients treated with daunorubicin].
Marty, M. E., Ganem, G., Fischer, J., Flandrin, G., Berger, R., Schaison, G., Degos, L., & Boiron, M. (1984) · PubMed · Cited by 62
Fukutani, H., Naoe, T., Ohno, R., Yoshida, H., Miyawaki, S., Shimazaki, C., Miyake, T., Nakayama, Y., Kobayashi, H., & Goto, S. (1995) · PubMed · Cited by 53
Michieli, M., Damiani, D., Ermacora, A., Geromin, A., Michelutti, A., Masolini, P., & Baccarani, M. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01957.x · Cited by 48
Bergstrom, S. K., Gillan, E., Quinn, J. J., & Altman, A. J. (1998) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199811000-00006 · Cited by 46
The role of bone marrow transplantation in acute promyelocytic leukemia
Nabhan, C., Mehta, J., & Tallman, M. S. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703119 · Cited by 46
Self-citationTakeshita, A., Shinjo, K., Naito, K., Ohnishi, K., Sugimoto, Y., Yamakawa, Y., Tanimoto, M., Kitamura, K., Naoe, T., & Ohno, R. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01823.x · Cited by 32
Anthracycline‐induced cardiotoxicity in children with malignancies
GODOY, L. Y., Fukushige, J., Igarashi, H., Matsuzaki, A., & Ueda, K. (1997) · Pediatrics International · doi:10.1111/j.1442-200x.1997.tb03579.x · Cited by 28
Treatment of Newly-Diagnosed Acute Promyelocytic Leukemia with Liposomal All-Trans Retinoic Acid
Estey, E. H., Koller, C. A., Cortes, J. E., Reed, P. J., Freireich, E. J., Giles, F. J., & Kantarjian, H. M. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109064587 · Cited by 21
Pediatric Primary Diffuse Large Cell Lymphoma of Bone With t(3;22)(q27;q11)
Antillón‐Klussmann, F., Behm, F. G., Raimondi, S. C., Kaste, S. C., Sandlund, J. T., & Pappo, A. S. (1998) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199811000-00008 · Cited by 13
Cited by
Sanz, M. A., Grimwade, D., Tallman, M. S., Lowenberg, B., Fenaux, P., Estey, E. H., Naoe, T., Lengfelder, E., Büchner, T., Döhner, H., et al. (2009) · Blood · doi:10.1182/blood-2008-04-150250 · Cited by 947
Self-citationMechanisms and insights into drug resistance in cancer
Zahreddine, H., & Borden, K. L. B. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00028 · Cited by 660
Map kinase signaling pathways and hematologic malignancies
Platanias, L. C. (2003) · Blood · doi:10.1182/blood-2002-12-3647 · Cited by 432
de la Serna, J., Montesinos, P., Vellenga, E., Rayón, C., Parody, R., León, A., Esteve, J., Bergua, J. M., Milone, G., Debén, G., et al. (2008) · Blood · doi:10.1182/blood-2007-07-100669 · Cited by 350
Metadata
- Authors
- Tallman, M. S., Nabhan, C., Feusner, J. H., & Rowe, J. M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2002-02-01
- Volume
- 99
- Issue
- 3
- Pages
- 759-767
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2050863148
- Cited by
- 398
- References
- 66
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.